Barry Moze is EVP, Chief Admin. Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 138,174 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2022, when has been sold 49,841 shares (Ordinary Shares) at a price of $101.84 per share, resulting in proceeds of $5,075,807. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 138K
0% 3M change
0% 12M change
Total Value Held $0

BARRY MOZE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2022
SELL
Payment of exercise price or tax liability
$5,075,807 $101.84 p/Share
49,841 Reduced 26.51%
138,174 Ordinary Shares
Jan 05 2022
BUY
Exercise of conversion of derivative security
-
64,959 Added 31.59%
140,640 Ordinary Shares
Jan 05 2022
BUY
Grant, award, or other acquisition
-
47,375 Added 20.13%
188,015 Ordinary Shares
Nov 04 2021
SELL
Open market or private sale
$8,558,201 $112.99 p/Share
75,743 Reduced 50.02%
75,681 Ordinary Shares
Nov 04 2021
BUY
Exercise of conversion of derivative security
$1,222,492 $16.14 p/Share
75,743 Added 33.34%
151,424 Ordinary Shares
Jul 28 2021
SELL
Payment of exercise price or tax liability
$329,538 $102.5 p/Share
3,215 Reduced 4.07%
75,681 Ordinary Shares
Jul 28 2021
BUY
Grant, award, or other acquisition
-
7,257 Added 8.42%
78,896 Ordinary Shares
Jul 08 2021
SELL
Open market or private sale
$3,239,970 $92.37 p/Share
35,076 Reduced 32.87%
71,639 Ordinary Shares
Apr 12 2021
SELL
Open market or private sale
$5,874,332 $89.53 p/Share
65,613 Reduced 38.31%
105,665 Ordinary Shares
Feb 17 2021
SELL
Payment of exercise price or tax liability
$75,925 $87.17 p/Share
871 Reduced 0.51%
171,278 Ordinary Shares
Feb 17 2021
BUY
Grant, award, or other acquisition
-
1,965 Added 1.13%
172,149 Ordinary Shares
Jan 21 2021
SELL
Payment of exercise price or tax liability
$199,615 $77.43 p/Share
2,578 Reduced 1.49%
170,184 Ordinary Shares
Jan 21 2021
BUY
Exercise of conversion of derivative security
-
5,819 Added 3.26%
172,762 Ordinary Shares
Jan 05 2021
SELL
Payment of exercise price or tax liability
$1,908,174 $36.1 p/Share
52,858 Reduced 24.05%
166,943 Ordinary Shares
Jan 05 2021
BUY
Grant, award, or other acquisition
-
65,089 Added 22.85%
219,801 Ordinary Shares
Jan 05 2021
BUY
Exercise of conversion of derivative security
-
54,003 Added 25.87%
154,712 Ordinary Shares
Nov 05 2020
SELL
Open market or private sale
$6,189,925 $79.87 p/Share
77,500 Reduced 43.49%
100,709 Ordinary Shares
Jul 07 2020
BUY
Exercise of conversion of derivative security
$496,325 $14.15 p/Share
35,076 Added 16.45%
178,209 Ordinary Shares
Jul 01 2020
SELL
Open market or private sale
$1,274,153 $55.02 p/Share
23,158 Reduced 13.93%
143,133 Ordinary Shares
Mar 30 2020
SELL
Open market or private sale
$59,347 $28.18 p/Share
2,106 Reduced 1.25%
166,291 Ordinary Shares
Mar 30 2020
BUY
Exercise of conversion of derivative security
$27,252 $12.94 p/Share
2,106 Added 1.24%
168,397 Ordinary Shares
Feb 19 2020
SELL
Payment of exercise price or tax liability
$239,763 $36.06 p/Share
6,649 Reduced 3.84%
166,291 Ordinary Shares
Feb 19 2020
BUY
Grant, award, or other acquisition
-
15,007 Added 7.98%
172,940 Ordinary Shares
Jan 21 2020
SELL
Payment of exercise price or tax liability
$98,608 $38.25 p/Share
2,578 Reduced 1.61%
157,933 Ordinary Shares
Jan 21 2020
BUY
Grant, award, or other acquisition
-
5,819 Added 3.5%
160,511 Ordinary Shares
BM

Barry Moze

EVP, Chief Admin. Officer
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP